General MedicationsORALStandard
FOSAMPRENAVIR CALCIUM
FOSAMPRENAVIR CALCIUM
Standard Dose
EQ 700MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview FOSAMPRENAVIR CALCIUM is listed in Drugs@FDA under application 204060 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient FOSAMPRENAVIR CALCIUM Form and strength TABLET;ORAL - EQ 700MG BASE Sponsor MYLAN Submission history Latest submission status date: 2021-03-19 00:00:00.
Structured Monograph
Clinical summary
Approval overview FOSAMPRENAVIR CALCIUM is listed in Drugs@FDA under application 204060 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FOSAMPRENAVIR CALCIUM Form and strength TABLET;ORAL - EQ 700MG BASE Sponsor MYLAN Submission history Latest submission status date: 2021-03-19 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.